Batoni G, Bottai D, Esin S, Florio W, Pardini M, Maisetta G, Freer G, Senesi S, Campa M
Dipartimento di Patologia Sperimentale, Biotecnologie Mediche, Infettivologia ed Epidemiologia, University of Pisa, Via S. Zeno 35-39, 56127, Italy.
Scand J Immunol. 2002 Jul;56(1):43-51. doi: 10.1046/j.1365-3083.2002.01104.x.
Mycobacterium tuberculosis (MTB) secretory proteins are generally considered important antigens for immune protection against tuberculosis (TB). An 8.3-kDa secretory antigen of MTB and Mycobacterium bovis bacillus Calmette-Guérin (BCG), called SA5K, was recently identified and cloned in our laboratory. In this report, recombinant SA5K containing a histidine hexamer was expressed in Escherichia coli and purified to investigate its biochemical structure and to establish whether it was immunogenic for healthy sensitized and nonsensitized human donors and for patients infected with MTB. The protein nucleotide sequence was shown to be identical in BCG and in MTB. SA5K revealed an abnormal electrophoretic mobility in SDS-PAGE that made it look lighter than it is in Western blotting. While recombinant SA5K was poorly recognized by T lymphocytes from patients with pulmonary TB, it elicited proliferation of CD4+ T lymphocytes in the vast majority of healthy individuals sensitized to mycobacterial antigens by BCG vaccination. At a serum dilution of 1 : 80, antibodies reacting against recombinant SA5K were found in 67% of sera from TB patients and in 73% of sera from healthy subjects. The percentage of positive subjects dropped at higher serum dilutions, but no significant difference in the recognition rate was observed between TB patients and healthy donors and between healthy vaccinated and nonvaccinated subjects. Owing to the high percentage of sera from healthy subjects who recognized SA5K in Western blotting, the antigen seems to exhibit, at least in the present form, a poor specificity for an employment for a serodiagnosis of TB.
结核分枝杆菌(MTB)分泌蛋白通常被认为是抗结核病免疫保护的重要抗原。最近,在我们实验室中鉴定并克隆了一种MTB和卡介苗(BCG)的8.3 kDa分泌抗原,称为SA5K。在本报告中,含有组氨酸六聚体的重组SA5K在大肠杆菌中表达并纯化,以研究其生化结构,并确定它对健康的致敏和未致敏人类供体以及MTB感染患者是否具有免疫原性。该蛋白的核苷酸序列在BCG和MTB中显示相同。SA5K在SDS-PAGE中显示出异常的电泳迁移率,使其在蛋白质印迹中看起来比实际分子量更轻。虽然重组SA5K在肺结核患者的T淋巴细胞中识别性较差,但它在绝大多数通过卡介苗接种对分枝杆菌抗原有致敏反应的健康个体中引发了CD4+ T淋巴细胞的增殖。在血清稀释度为1:80时,67%的肺结核患者血清和73%的健康受试者血清中发现了与重组SA5K反应的抗体。在更高的血清稀释度下,阳性受试者的百分比下降,但在肺结核患者和健康供体之间以及健康接种和未接种受试者之间,识别率没有观察到显著差异。由于在蛋白质印迹中识别SA5K的健康受试者血清比例很高,该抗原似乎至少以目前的形式表现出对用于结核病血清诊断的特异性较差。